IPP Bureau
GlycoEra AG appoints Tanmoy Ganguly as Chief Scientific Officer
By IPP Bureau - June 17, 2022
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Valo Therapeutics appoints Hemanshu Shah as Chief Business Officer
By IPP Bureau - June 17, 2022
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Saint-Gobain Life Sciences expands manufacturing facility in Japan
By IPP Bureau - June 17, 2022
The capacity addition in Suwa is part of Saint-Gobain Life Sciences ongoing investment plan to globally expand production capacity for its products and services used throughout the bioprocessing industry
COVID-19 infected 9-year-child successfully gets a heart transplant at Masinda Heart Institute
By IPP Bureau - June 16, 2022
Many kids who have heart transplants live a normal, healthy life once they recover from surgery.
Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research
By IPP Bureau - June 16, 2022
The nadAROSE and nadia3D kits address the needs of researchers exploring both agarose encapsulation and collagen-based hydrogel projects for the 3D cell culture space.
Sir H N Reliance Foundation Hospital performs India’s first Sapien3 Tricuspid implant
By IPP Bureau - June 16, 2022
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Syntegra partners with TMA Precision to reduce the diagnostic odyssey for rare disease with synthetic data-enabled tools
By IPP Bureau - June 16, 2022
TMA will leverage Syntegra's synthetic data engine to accelerate the building of predictive diagnostic algorithms
Enko advances Enkompass platform through DNA-encoded library technology
By IPP Bureau - June 16, 2022
Large datasets will train machine learning models and speed up agile discovery of novel crop protection solutions
Lupin Diagnostics launches its first regional reference lab in Patna
By IPP Bureau - June 16, 2022
Expanding diagnostics footprint in East India
Glenmark becomes the first company to launch Indacaterol + Mometasone FDC for asthma in India
By IPP Bureau - June 16, 2022
Glenmark is the first company in India to market the innovative FDC of Indacaterol
Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation
By IPP Bureau - June 16, 2022
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
LG Chem’s new drug for obesity receives additional orphan drug designation by US FDA
By IPP Bureau - June 16, 2022
With this designation, LG Chem will receive benefits such as exclusive sales rights in the US market for seven years, subsidies and tax cuts for clinical testing costs in the US, and preliminary consulting support related to development
80% of hypertensive women found to be obese: Study
By IPP Bureau - June 16, 2022
48% of people are either hypertensive or at risk of becoming hypertensive & 30% of people have a high Waist Hip Ratio (WHR) – an early indication of the onset of CVDs
QIAGEN selects TCS for cloud transformation strategy
By IPP Bureau - June 16, 2022
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
Apollo Hospitals completes a procedure using new technology SENTINEL
By IPP Bureau - June 16, 2022
Apollo Hospitals Chennai is the first healthcare institution in South India to use this protected TAVI / TAVR technology.
